Literature DB >> 1678270

The description and prediction of antihypertensive drug response: an individualised approach.

R Donnelly1, P A Meredith, H L Elliott.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1678270      PMCID： PMC1368571          DOI： 10.1111/j.1365-2125.1991.tb05584.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  37 in total

1.  Varying responses to hypotensive agents in different racial groups: black versus white differences.

Authors:  Y K Seedat
Journal:  J Hypertens       Date:  1989-07       Impact factor: 4.844

2.  Initial blood pressure as a predictor of the response to antihypertensive therapy.

Authors:  D J Sumner; P A Meredith; C A Howie; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1988-12       Impact factor: 4.335

3.  Propranolol therapy in essential hypertension. Observations on predictability of therapeutic response.

Authors:  L Hansson; A J Zweifler; S Julius; C N Ellis
Journal:  Int J Clin Pharmacol       Date:  1974-09

4.  Individualization of antihypertensive therapy.

Authors:  J Ménard; H R Brunner; B Waeber; P F Plouin; M Burnier
Journal:  Hypertension       Date:  1988-11       Impact factor: 10.190

Review 5.  Hypertension 1988: present challenges and future strategies.

Authors:  J L Reid
Journal:  J Hypertens       Date:  1988-01       Impact factor: 4.844

6.  Plasma concentrations of propranolol in patients with essential hypertension.

Authors:  A Lehtonen; J Kanto; T Kleimola
Journal:  Eur J Clin Pharmacol       Date:  1977-03-11       Impact factor: 2.953

7.  Pharmacokinetics of repeated single oral doses of enalapril maleate (MK-421) in normal volunteers.

Authors:  A E Till; H J Gomez; M Hichens; J A Bolognese; W R McNabb; B A Brooks; F Noormohamed; A F Lant
Journal:  Biopharm Drug Dispos       Date:  1984 Jul-Sep       Impact factor: 1.627

Review 8.  An overview of the clinical pharmacology of enalapril.

Authors:  R O Davies; H J Gomez; J D Irvin; J F Walker
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

9.  Ketanserin concentration-effect relationships in individual hypertensive patients.

Authors:  R Donnelly; H L Elliott; P A Meredith; D M Hughes; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1988-07       Impact factor: 4.335

10.  Long-term clinical experience with enalapril in essential hypertension.

Authors:  H R Brunner; B Waeber; J Nussberger; M D Schaller; H J Gomez
Journal:  J Hypertens Suppl       Date:  1983-10
View more
  4 in total

1.  Evaluation of the angiotensin challenge methodology for assessing the pharmacodynamic profile of antihypertensive drugs acting on the renin-angiotensin system.

Authors:  C Buchwalder-Csajka; T Buclin; H R Brunner; J Biollaz
Journal:  Br J Clin Pharmacol       Date:  1999-10       Impact factor: 4.335

Review 2.  Concentration-effect analysis of antihypertensive drug response. Focus on calcium antagonists.

Authors:  R Donnelly; H L Elliott; P A Meredith
Journal:  Clin Pharmacokinet       Date:  1994-06       Impact factor: 6.447

Review 3.  Is there a concentration-effect relationship for sulphonylureas?

Authors:  A Melander; R Donnelly; T Rydberg
Journal:  Clin Pharmacokinet       Date:  1998-03       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics and kinetic-dynamic relationships of dilevalol and labetalol.

Authors:  R Donnelly; G J Macphee
Journal:  Clin Pharmacokinet       Date:  1991-08       Impact factor: 6.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.